- Home
- MHH vs MIRM Comparison
MHH vs MIRM Comparison
Compare MHH & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MHH | MIRM |
|---|---|---|
| Founded | 1986 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.7M | 3.4B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | MHH | MIRM |
|---|---|---|
| Price | $7.35 | $69.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $88.36 |
| AVG Volume (30 Days) | 37.4K | ★ 602.6K |
| Earning Date | 11-12-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $196,657,000.00 | ★ $471,794,000.00 |
| Revenue This Year | N/A | $53.78 |
| Revenue Next Year | $4.52 | $19.91 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 1.24 | ★ 53.66 |
| 52 Week Low | $6.20 | $36.88 |
| 52 Week High | $16.00 | $78.55 |
Technical Indicators
Market Signals| Indicator | MHH | MIRM |
|---|---|---|
| Relative Strength Index (RSI) | 53.19 | 50.63 |
| Support Level | $6.79 | $63.23 |
| Resistance Level | $7.71 | $66.77 |
| Average True Range (ATR) | 0.58 | 3.05 |
| MACD | -0.00 | -0.16 |
| Stochastic Oscillator | 49.08 | 49.52 |
Price Performance
Historical ComparisonAbout MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.